Investor Overview

Corporate Profile

vTv Therapeutics is a clinical-stage biotechnology company committed to improving the lives of diabetes patients.

vTv has a pipeline of clinical drug candidates developed using our innovative technology and led by our TTP399 program for the treatment of type 1 diabetes. vTv’s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease, psoriasis, atopic dermatitis, renal disease, primary mitochondrial myopathy, and pancreatic cancer.

More >>

Recent News

Date Title
Toggle Summary vTv Therapeutics Shares Updated Corporate Presentation
HIGH POINT, N.C. , Jan. 13, 2022 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical-stage biopharmaceutical company committed to improving the quality of life for people with diabetes, is sharing its updated corporate presentation highlighting its lead program TTP399, a novel oral
View HTML
Toggle Summary vTv Therapeutics Announces Restructuring to Prioritize its Lead Program and Focus Operations
-Workforce reduction of 65% -Prioritization of lead program TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabetes patients HIGH POINT, N.C. , Dec. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc.
View HTML
Toggle Summary vTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update
HIGH POINT, N.C. , Nov. 09, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the third quarter ended September 30, 2021 , and provided an update on the progress of its clinical programs. “We plan to refocus vTv’s strategy on TTP399.  TTP399 is unique
View HTML
Toggle Summary vTv Therapeutics Announces Deepa Prasad as New President and CEO
HIGH POINT, N.C. , Oct. 20, 2021 /PRNewswire/ --  vTv Therapeutics Inc.  (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and psoriasis, today announced that Deepa Prasad will lead the company as President and
View HTML
Recent Presentation
More >>
Upcoming Events
More events are coming soon.

Receive E-mail Alerts

Click here to sign up to receive e-mail alerts whenever vTv Therapeutics Inc. posts new information to the site.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.